Want to see FR:CVX full AI Analyst Report?
Affluent Medical SA (CVX) Stock Statistics & Valuation Metrics
Total Valuation
Affluent Medical SA has a market cap or net worth of EUR 331.05M. The enterprise value is EUR 204.58M.
- Market Cap
- EUR 331.05M
- Enterprise Value
- EUR 204.58M
Share Statistics
Affluent Medical SA has 62,278,385 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 62,278,385
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Affluent Medical SA’s return on equity (ROE) is -4.50 and return on invested capital (ROIC) is -48.28%.
- Return on Equity (ROE)
- -4.50
- Return on Assets (ROA)
- -0.52
- Return on Invested Capital (ROIC)
- -48.28%
- Return on Capital Employed (ROCE)
- -0.74
- Revenue Per Employee
- 0
- Profits Per Employee
- -244.81K
- Employee Count
- 102
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Affluent Medical SA is -8.12. Affluent Medical SA’s PEG ratio is 0.12.
- PE Ratio
- -8.12
- PS Ratio
- 0.00
- PB Ratio
- 6.76
- Price to FCF
- -11.43
- Price to Operating Cash Flow
- -16.31
- PEG Ratio
- 0.12
Income Statement
In the last 12 months, Affluent Medical SA had revenue of 0 and earned -24.97M in profits. Earnings per share was -0.63.
- Revenue
- 0
- Gross Profit
- -2.19M
- Operating Income
- -18.00M
- Pretax Income
- -26.01M
- Net Income
- -24.97M
- EBITDA
- -15.81M
- Earnings Per Share (EPS)
- -0.63
Cash Flow
In the last 12 months, operating cash flow was -17.98M and capital expenditures -153,000, giving a free cash flow of -18.13M billion.
- Operating Cash Flow
- -17.98M
- Free Cash Flow
- -18.13M
- Free Cash Flow per Share
- -0.33
Dividends & Yields
Affluent Medical SA pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -8.75%
- Earnings Yield
- -10.06%
Stock Price Statistics
- Beta
- 0.40
- 52-Week Price Change
- 232.08%
- 50-Day Moving Average
- 5.78
- 200-Day Moving Average
- 4.38
- Relative Strength Index (RSI)
- 41.79
- Average Volume (3m)
- 27.01K
Important Dates
Affluent Medical SA upcoming earnings date is ―, During Market Hours (Confirmed).
- Last Earnings Date
- Sep 30, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Affluent Medical SA as a current ratio of 0.30, with Debt / Equity ratio of 433.11%
- Current Ratio
- 0.30
- Quick Ratio
- 0.30
- Debt to Market Cap
- 0.34
- Net Debt to EBITDA
- -1.41
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Affluent Medical SA has paid -1.04M in taxes.
- Income Tax
- -1.04M
- Effective Tax Rate
- 0.04
Enterprise Valuation
Affluent Medical SA EV to EBITDA ratio is -10.77, with an EV/FCF ratio of -12.47.
- EV to Sales
- 0.00
- EV to EBITDA
- -10.77
- EV to Free Cash Flow
- -12.47
- EV to Operating Cash Flow
- -12.58
Balance Sheet
Affluent Medical SA has EUR 7.02M in cash and marketable securities with EUR 19.48M in debt, giving a net cash position of -EUR 12.46M billion.
- Cash & Marketable Securities
- EUR 7.02M
- Total Debt
- EUR 19.48M
- Net Cash
- -EUR 12.46M
- Net Cash Per Share
- -EUR 0.20
- Tangible Book Value Per Share
- -EUR 0.68
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Affluent Medical SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -100.00%
- EPS Growth Forecast
- -72.33%
Scores
- Smart Score
- ―
- AI Score
- 52
